key: cord-0913613-l5uy50lj authors: Borgsteede, Sander D.; Geersing, Tjerk H.; Tempels‐Pavlica, Žana title: Other excipients than PEG might cause serious hypersensitivity reactions in COVID‐19 vaccines date: 2021-06-15 journal: Allergy DOI: 10.1111/all.14774 sha: 3b9f1487cec726503df7b01a1f0c052240d1081d doc_id: 913613 cord_uid: l5uy50lj nan To the Editor, The availability of new vaccines against SARS-CoV-2 brings promising opportunities to prevent people from getting infected and developing COVID-19. As with other drugs, vaccines can cause adverse drug reactions (ADRs). Although generally the ADRs to vaccines are mild and serious reactions are very rare, 1 anaphylactic reactions were reported after administration of COVID-19 vaccines. 2 Cabanillas et al provide valuable background information that these anaphylactic reactions might be caused by polyethylene glycols (PEGs) that are part of lipid nanoparticles (LNPs) of mRNA-vaccines. 2 We agree that Table 1 lists the excipients of the vaccines currently used in the European c No hypersensitivity reactions have been reported, yet reactions to other phospholipids in pollen were described. 4 Vaccine-associated hypersensitivity Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol? Development of stable liquid formulations for adenovirus-based vaccines Human CD1-restricted T cell recognition of lipids from pollens Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging Systemic allergy to EDTA in local anesthetic and radiocontrast media